Roxane launches generic Amerge, Arimidex

COLUMBUS, Ohio Roxane Labs announced Thursday the launch of two new generic drugs.

The Columbus, Ohio-based generics subsidiary of German drug maker Boehringer Ingelheim, launched naratriptan tablets in the 1-mg and 2.5-mg strengths, and anastrozole tablets in the 1-mg strength.

Naratriptan tablets are used to treat acute migraine and are a generic version of GlaxoSmithKline’s Amerge, which had annual sales of around $60.2 million, according to IMS Health. Anastrozole is used to treat postmenopausal women with breast cancer and is a generic version of AstraZeneca’s Arimidex, which had annual sales of around $916.8 million.